Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

Zohra Nooruddin, MD, Zenggang Pan, MD PhD, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, MD MPH, MS, Daniel A Pollyea, MD, Jonathan A Gutman, MD, William Robinson, MD PhD, Clayton Smith, MD FRCPC, Jeffrey Schowinsky, MD, Purev Enkhtsetseg, MD, Daniel W. Sherbenou, MD PhD, Rachel Rabinovitch, MD, Douglas Ney, MD, Craig T Jordan, PhD, Manali Kamdar, MD

Blood (2016) 128 (22): 3054.

https://doi.org/10.1182/blood.V128.22.3054.3054

Published: 2016

Journal Articles

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Zohra Nooruddin, MD, William Robinson, MD PhD, Daniel Pollyea, MD MS, Jonathan A Gutman, MD, Clayton Smith, MD FRCPC, Zenggang Pan, MD, Craig T Jordan, PhD, Rachel Rabinovitch, MD, Jeffrey Schowinsky, Xian Lu, PhD, Douglas Ney, MD, Manali Kamdar, MD

Blood (2015) 126 (23): 1443.

https://doi.org/10.1182/blood.V126.23.1443.1443

Published: 2015

Journal Articles

Presence of Dysregulated Immune Recovery (IMD) Following Autotransplant May Change the Type of Predominant Serum Light Chain and Elevate the Level in Patients with Multiple Myeloma (MM).

Choon Kee Lee, MD, Mary Berg, MD, John Ryder, Han Myint, FRCP, FRCPath, J. Fred Kolhouse, MD, William Robinson, MD

Blood (2009) 114 (22): 4870.

https://doi.org/10.1182/blood.V114.22.4870.4870

Published: 2009

Journal Articles

Unremitting Presence of Marrow Immunoglobulin Heavy Chain Gene Rearrangement (IGH-GR) 3 Months Following Autotransplant Is Associated with Poor Outcome in Disease Control in Patients with Multiple Myeloma (MM).

Choon Kee Lee, MD, Qi Wei, Director, Laboratory, Develpment, Molecular, Diagnostics, Mark Lovell, Associate, Professor, Karen Swisshelm, Co-Director, John Ryder, Han Myint, FRCP, FRCPath, J. Fred Kolhouse, MD, William Robinson, MD

Blood (2009) 114 (22): 1807.

https://doi.org/10.1182/blood.V114.22.1807.1807

Published: 2009

Journal Articles

An Outcome Study On Survival and Disease Control in Patients with High-Risk Multiple Myeloma (MM) for Relapse, Treated with High-Dose Melphalan Combined with Bortezomib for Autotransplant Followed by Post-Transplant Maintenance with Bortezomib and Lenalidomide.

Choon Kee Lee, MD, Jeff Kaiser, Pharm., D., Han Myint, FRCP, FRCPath, Mary Berg, MD, J. Fred Kolhouse, MD, William Robinson, MD

Blood (2009) 114 (22): 3404.

https://doi.org/10.1182/blood.V114.22.3404.3404

Published: 2009

Journal Articles

Truncation in CCND1 mRNA 3′ UTR Is Associated with An Aggressive Phenotype and Chemoresistance

Robert W Chen, MD, Myo Htut, MD, Britta Hoehn, PhD, Eamon Berge, MD, William Robinson, MD, PhD, John Rossi, PhD, Stephen Forman, MD, Lynne Bemis, PhD

Blood (2008) 112 (11): 5287.

https://doi.org/10.1182/blood.V112.11.5287.5287

Published: 2008

Journal Articles

Role of MicroRNAs in Resistance to Dexamethasone in Multiple Myeloma Cell Lines

Qaiser Bashir, MD, Lynne Bemis, Ph.D, William Robinson, MD, Bolin Liu, Ph.D, Shuiliang Wang, Carol Amato, Elizabeth Riley, MD, Choon Kee Lee, MD

Blood (2008) 112 (11): 3680.

https://doi.org/10.1182/blood.V112.11.3680.3680

Published: 2008

Journal Articles

Differentially Cleaved Forms of Osteopontin by Thrombin and Carboxypeptidase B (TAFIa) Regulates Neutrophil Viability and Synoviocyte Binding in Rheumatoid Arthritis

Shadi Sharif, MS, Xiaoyan Du, PhD, Timothy Myles, PhD, Jason Jungsik Song, MD, Elizabeth A Price, MD, MPH, David Lee, MD, PhD, Stuart Goodman, MD, John Morser, PhD, William Robinson, MD, PhD, Lawrence L. Leung, MD

Blood (2008) 112 (11): 3562.

https://doi.org/10.1182/blood.V112.11.3562.3562

Published: 2008

Journal Articles

Treatment of Extranodal Marginal Zone Lymphoma and Primary Cutaneous B Cell Lymphoma with Rituximab: A Single Institution Experience.

Robert Chen, MD, Glen Peterson, NP, Diana Vucurevich, NP, Choon-kee Lee, MD, William Robinson, MD, Han Myint, MD, FRCP

Blood (2007) 110 (11): 4502.

https://doi.org/10.1182/blood.V110.11.4502.4502

Published: 2007

NARROW

Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes

IHC Analysis and Prognostic Factors in Post Transplant Lymphoproliferative Disorders after Solid Organ Transplantation: A Single Center Experience

Presence of Dysregulated Immune Recovery (IMD) Following Autotransplant May Change the Type of Predominant Serum Light Chain and Elevate the Level in Patients with Multiple Myeloma (MM).

Unremitting Presence of Marrow Immunoglobulin Heavy Chain Gene Rearrangement (IGH-GR) 3 Months Following Autotransplant Is Associated with Poor Outcome in Disease Control in Patients with Multiple Myeloma (MM).

An Outcome Study On Survival and Disease Control in Patients with High-Risk Multiple Myeloma (MM) for Relapse, Treated with High-Dose Melphalan Combined with Bortezomib for Autotransplant Followed by Post-Transplant Maintenance with Bortezomib and Lenalidomide.

Truncation in CCND1 mRNA 3′ UTR Is Associated with An Aggressive Phenotype and Chemoresistance

Role of MicroRNAs in Resistance to Dexamethasone in Multiple Myeloma Cell Lines

Differentially Cleaved Forms of Osteopontin by Thrombin and Carboxypeptidase B (TAFIa) Regulates Neutrophil Viability and Synoviocyte Binding in Rheumatoid Arthritis

Treatment of Extranodal Marginal Zone Lymphoma and Primary Cutaneous B Cell Lymphoma with Rituximab: A Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only